NCT05947669: Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
- State
- Under way
- Phase
- Phase 3
- People
- 195 planned
- Started
- 22 Aug 2023
- Primary completion
- Sep 2026
- Arms
- Treatment with infliximab
- Results
- None posted
- 17 Jul 2023: Trial registered
- 22 Aug 2023: Trial started